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Consumpti on
of Omega-3 Fatty Acid-Enriched Eggs
and Serum Lipids in HUlnans
Ji- Young Lee
Nancy M. Lewis
Sheila E. Scheideler
Timothy P. Carr

ABSTRACT. This study examined the effectiveness of consuming
omega-3 fatty acid-enriched eggs (Omega Eggs) in increasing rotal diclary omcga-3 fatty acids. Also examined was the impact of OmegaE~gg
consumption on serum lipids. Sixteen hypercholesterolemic men and
women with baseline serum total cholesterol concentrations of 5. J 7-7.76
mmoliL (200-300 mg/dL) followed the National Cholesterol Education
Program Step I diet guidelines under the following conditions: (a) Step 1
diet without eggs, (b) Step I diet plus 12 regular eggs per week, and
(c) Step I diet plus 12 Omega Eggs per week. The study design was a repeated 3 X 3 Latin square so that each subject received each of the three
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diet treatments. Consumption of Omega Eggs significantly increased
omega-3 fatty aeid intake (1.18 g/day) compared to consumption ot regular eggs (0.71 g/day) or no eggs (0.81 g/day). The Omega Egg treatment
did not significantly alter serum eholesterol or triacylglycerol concentralion when all ] 6 subjects were included in the analysi~. However, three
subjects showed a significant increase in serum total cholesterol coneentration when consuming regular eggs relative to no eggs. When these
"responders" consumed Omega Eggs, serum tolal cholesterol concentration did not increase, despite a 3-fold increase in cholesterol intake rela··
live to no egg treatment. These data suggest that Omega Eggs (12/week)
can be included in the National Cholesterol Education Program Step I
diet without increased serum total cholesterol or triacylglycerol concentration. In this way, [he nutritional benefits of eggs could be realized
without the detrimental effects of increased cholesterol intake. fAr/iele
copies {{vailable for a fee from The Hmvorth Documem J)elivery Service:
J ·800·H,1 WORTH E·mail address: <getinji-!@haw(Jr/hpress.coll1> Wehsite:
<hflp.//www.HaworIIiPress.com> © 2003 by The Haworrh Press, fllc. All rights
reserved.}
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INTRODUCTION
Consumption of fish rich in omcga-3 PUFA in the United States is
approximately One serving per week,) while the dietary recommendation i.s one to l\vO fish meals per wcck 2 Because the intake of fish is generally low. finding altemative sources of omega-3 PUFA is necessary to
increase the omega-3 PUFA consumption in the United States and other
countdes.
Eggs have been studied as an alternative food source of ornega-3
PUFA because they can be produced with an altered fatty acid composition, depending on the hens' feed.HIt is reported that inclusion of variellis sources of orncga-3 PUFA in hens' feed resulted in up to 220 mg of
ornega-3 PUPA per egg yolk, equivalent to the amount of omega-3
PUPA in a 100 g serving of lean fish. 'i Marshall et a1. 6 repOlted that
omega-3 fatty acid-enriched eggs could be incorporated as an omega-3
PlJFA source into the diet of health-conscious consumers.
Epidemiological studies in Greenland Eskimos led to the hypothesis
that fish oil rich in omega·3 polyunsaturated fatty acids (PUFA) re-
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duces the risk of atherosclerosis. 7-9 Research has shown that dietary
omega-3 PUFA reduce atherosclerosis development, at least in part, by
regulating serum cholesterol and triacylglycerol concentration W
A few studies have been conducted to investigate the effects of
omega-3 fatty acid-enriched eggs on plasma lipid concentration. The
con:;,umption of four omega-3 fatty acid-enriched eggs per day resulted
in lowered plasma triacylglycerol concentration and systolic and diastolic blood pressure, although plasma cholesterol concentration was
not affected. I 1 Ferrier et a1. 12 reponed that incorporation offour a-linolenic
acid-enriched eggs per day to the typical diets of nOlmolipidemics had
no significant effect on SellJITI cholesterol or triacylglycerol concentration. In contrast, Jiang and Sim 13 showed that rats consuming omega-3
PUFA-enriched egg yolks reduce both plasma and liver cholesterol
concentration. More research is needed to further delineate the role of
dietary orncga-3 fatty acid-enriched eggs in regulating plasma lipid
conccntrations. Therefore, the present study was conducted to determine the serum lipid response in hypercholesterolcrnic humans consuming eggs enriched in omega-3 fatty acids.

MATERIALS AND METHODS
Slll~iects

Subjects represent a subset of individuals who participated in a larger
study previously pubJished 14 Thc sixteen subjects selectcd for this
study are those that successfully completed all three treatment periods
described below. Volunteers were recruited through advertisements
and f1yers directed toward individuals whose serum tOlal cholesterol
levels were 5.17-7.76 111M (200-300 mg/dL) and considered hypercholesterolemic. They were screened for general good health and willingness to comply with the procedures of the study. People who had
health risks or factors affecting serum cholesterollevcls were excluded.
The exclusion critelia were: Pregnant or lactating women wishing to
conceive over the period of study; tobacco users; alcohol users more
than two drinks per day; regular users of prescription dllJgS for lowering
cholesterol; regular blood donors and not willing to forgo this activity
during the study; subjects allergic to eggs or egg products; subjects
planning a weight-loss diet; subjects who experienced an addiction to
drugs or alcohol within the last two years; subjects with high blood
prcssurc; and subjects with a body mass index t,'Teatcr than 32.5 kg/m2
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Diets and Experimental Design
The dietary protocol was based on the National Cholesterol Education Program (NCEP) Step T diet which suggests 3()% of total calories
from fat, 10% total calories from saturated fat, and less than 300 mg/day
of dietary cholesterol. J 5 Each subject was instructed to keep this diet regime throughout the study. Diet records were kept for three non-consecutive days during the last two weeks of each six-week treatment period
and were analyzed using the Food Processor Plus computer program,
Version 5.0 (ESHA Research, Salem, OR). Table I shows the diet COIllpositions during each treatment period.
Three diet treatments were used in this study: (l) NCEP Step I diet
and no egg, (2) NCEP Step I diet plus 12 regular eggs per week, and
(3) NCEP Step I diet plus 12 omega-3 fatty acid-enriched eggs per
week. The study design was a repeated 3 X 3 Latin square such that
each subject received each of the three diet treatments. After a twoweek baseline period WId six week-stabilization period for the Step I
diet, diet treatments were randomly assigned to subjects in a manner
consistent with the Latin square protocol. Each diet treatment was conducted for six weeks, with six-week washout periods between treatments to minimize possible carryover effects.
TABLE 1. Diet composition during treatment penods
Treatrnent

No Egg

± 0,45

Total Energy, Jlday

7.47

Total Fat, % energy

25.2 ± 1.5

Regular Egg

Omega Egg

7,53±0.41

7431: 040

26.3

1.6

25.6:1: 1,6

SFA, % energy

7,(;9

i: 0,61

8,58:! 0.64

7,85:t 0.47

MlIFA, % energy

8.67 t.0.60

9.86 ± 069

9.40 t 0.65

PlIFA, % energy

5.68t 0.53

5.22 ± 0.37

556 ± 0.44

Omoga-3 FA, g/day

0811:0.148

0.71 ± 0.08 a

1.18 ±0.12 b

Ornega-6 FA. glday

7.38 ± 0.92

6.96": 0.56

7.41±0.70

Omega-6/omega-3 FA ratio

10.5

Cholesterol, mg/day

± 0.9 b

157±178

10.7 ± 0.8

0

7.0i:0.8 "

475t29 b

477:! 24 b

VaitJes reprOsflnt mean -.~ SEM (n:::: 16 for each treatment). Va\ufls within the same row having different superscripts
are srgni1icantly different (P < 0,05), using one~way repeated meaSures ANOVA and Fisher's multiple comparison
test SFA, saturated fatty acids; MUFA, monounsaturated tatty acids; PUFA. pOlyunsaturated larty acids.
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The eggs used in this study were produced by the Dcpm1ment of Animal Science at the University of Nebraska-Lincoln. Regular eggs were
produced by feeding hens a standard diet. Omega-3 fatty acid-enriched
eggs (Omega Eggs) were produced utilizing a patented feeding formula
and management program. 16

Plasma and LDL Analysis
Blood samples were taken after 12 hour fasting at the fourth week of
each diet. Hed blood cells were removed and an aliquot of selllm was
frozen at - 70°C. Selllm was analyzed within 24 hours for total cholesterol, high density lipoprotein (HDL) cholesterol, total triacylgJycerol
concentration according to NCEP guidelines. 17 Serum low density lipoprotein (LDL) cholesterol concentration was calculated using the
Friedewald equation. IR
Selllm lipoprotcins wcre separated into fTaclions containing LDL
and HDL by gel filtration chromatography using 4IJo agarose (BioGel A
15m, 200 to 400 mesh, BioRad, Tnc., Hercules, CA) as described by
Rudel et al. 19 The composition of serum LDL was determined by quantifying the chemical components ofLDL particles (i.e., triacylglycerol,
cho1csteryl ester, free cholesterol, phospholipid, and apolipoprotein
B-lOO) as previously described 20 Briefly, serum LDL total cholesterol
and triacylgJycero] concentration was measured enzymatically using
commercially available reagents (Boehringer Mannheim, Indianapolis,
IN). Unesterified (free) cholesterol was also measured enzymatically
(Wako Chemicals USA, Inc., Richmond, VA). Esterified cholesterol
was determined as the difference between total and free cholesterol.
LDL phospholipids were estimated by measuring inorganic phosphorus
using the method of Monison 21 Apolipoprolein B-1 00 was measured
hy immllnoturbidimetric assay (Sigma Chemical Co., St. Louis, MO).
LDL particle diameter was calculaled according to the equation of Van
Heek and Zilversmit. 22

Statistical Analyses
Statistical comparison among treatment groups was determined by
repeated measures one-way anaJysis of variance and Fisher's least significant difference test using Sigl11aStat (SPSS Science, Chicago, IL).
Trcatmcnt differences were considered significant at the P < 0.05 level.
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RESULTS
Diet compositions from the analysis of diet records are shown in Table ] . Dietary intake was similar dm-jng each treatment period with regard to daily total energy intake and percent of energy from total fat,
saturated (SFA ), monounsaturated (MUFA), and polyunsaturated (PUF A)
fatty acids. The total daily intake of omega-3 fatty acids was significantly higher and the omega-6/omega-3 ratio was significantly lower
during Omega Egg treatment. Consumption of both Regular Eggs and
Omcga Eggs resulted in higher cholesterol intake (P < 0.05).
Serum lipid concentrations are shown in Table 2. No significant
treatment differences were detected in serum total, LDL, or HDL cholesterol or serum triacylglycerol. The chemical composition of serum
LDL was also analyzed Cfable 3). No significant treatment differences
were detected in the chemical composition of LDL expressed as the
number of lipid molecules per LDL particle. There was a tendency of
LDL molecular weight to be higher in the Regular Egg treatment, although this trend did not reach statistical significance.
Among the J 6 subjects there were three indi viduals whose serum total cholesterol concentration significantly increased during Regular
Egg treatment compared to No Egg treatment Crable 4). Omega Egg
treatment in these "cholesterol responders" prevented the increase in
serum total cho1esteIOI concentration, which was significantly lower
than Regular Egg treatment and similar to No Egg treatment. A similar
trend was observed in serum LDL cholesterol and triacylglycerol con ..
centration, but these ditlerences did not reach statistical significance.
TABLE 2. Serum lipid concentrations

No

Total Cholesterol

5.94" 0.20

5.96 cL 0.20

6.05:t 0.20

LDL C!lOlesterol

3.84±0.19

3.80 ± 0.21

3.95 ± 0.20

HDL Cholesterol

1.30 ± 0.08

1.37 ± 0.10

1.34 ± 0.08

Triacylglyceroi

1.75 ± 0.26

1.72 ± 0.26

1.66 ± 0.26

Values represent mean ± SEM (n =- 16 for each treatment). No significant differences were detected among trea1ment groups, using

one~way

mpeated measures ANOVA.
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TABLE 3. Serum LDL lipid composition, molecular weight, and particle diameter
...

--~

...---.----.-.-..-

Treatment

Cnoles!eryl Ester, molecules/particle
Triacylglycerol, molecules/particle

No Egg

Regular Egg

2202 ± 52

2240 ± 92

736

± 53

822

Omega Egg
2166± 132

± 114

698 ± 47

547:2: 41

575 ± 44

569 ± 50

Phospl,olipid, molecules/particle

1334 ± 47

1433:1: 80

1339 t .57

Molecular Weight, 9/)Jmo/e 1

3.84 ± 0.07

4.03:1: 0.19

3.80

Free Cholesterol, molecules/particle

LDL Diameter. angstroms

225± 5

0.17

216 ± 5

223.'.1,7

Values represent mann ± SEM (n = 16 for oRch treatment). No significant differences were dotected among treatusing one-v.,ray repeated measures ANOVA
ment
relors to tho mas,; (grams) of LDL lipid and
8-100 constituents pel
01
I
molecul.ar weight values were used to
LOt. MW: cholesteryl
650;
387; phospholipid, 775, and apotipoprolein 8-100, 513,000.

TABLE 4. Serum lipid concentration in responders and nonresponders
Responders (n = 3)
....

_._ ........_----..

No Egg

Nonresponders (n

Reqular Egg Omega Egg
....

No Egg

_-......._ - _ . . . . .

Regular Egg
------

= 13)
Omega Egg

mmalll

5.96,t: 0.20

5.87 :':. 0.21

6.06 ± 0.22

3.79:t,O.20

3.70:L 0.24

3.93 J'. 0.22

0.24

129t 0.15

1.33:t 0.09

1.40.'.0.11

1.35.;: 0.10

1.87 ± 0.58

1.44 ± 045

1.83 ± 0.31

1.69 ± 0.30

1.72 ±. 0.31

5.84 :t 0.69 " 6.35.l 0.56 b 5.97

LDt. Cholesterol

4.04 :t 0.65

4.26 :1: 048

HDL Cholesterol

1.15

1.24

Triacylglycerol

143 ± 0.38

-1,

0.'17

± 0.6:3 a

4.03:t,O.59

T olal Cholesterol

...

~-

..- - - - - - - - - -

Vaiues represent mean ± SEM. Values wi\hin !he same row having different supersCripts are slgnilicanUy differef\t
(P < 0.05), using o-re-way repea~ecJ measures ANOVA and Fisher's multiple comparison \est

DISCUSSION
This study was conducted to determine whether total omega-3 fatty
acid intake could be increased in a habitual diet by consuming eggs enriched in omega-3 fatty acids (Omega Eggs). Also examined was the
impact of consuming Omega Eggs on semrn lipid concentration and
LDL chemical composition. The results show that addition of Omega
Eggs to the subjects' diets significantly increased total orncga-3 fatty
acid intake compared to No Egg and Regular Egg treatment. Although
omega-3 fatty acid intake increased about 400-500 mg/day by consuming Omega Eggs, this dietary level had limited impact on serum lipids,
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Dietary linolenic acid (CI8:3) can be converted to docosahexaenoic
acid (C22:6) in the body, which is physiologically essential for normal
function of nervous tissue membranes. However, the enzymes involved
in this conversion are common to the pathway for the elongation and
dcsaturation of linoleic acid (C18:2), and competition with omega-6
fatty acids will reduce the amount of C18:3 converted to C22:6.23
Hence, dietary recommendations in Canada include an omega-6 to
omega-3 fatty acid ratio as low as 4: \ and not higher than 10: }24 The
omcga-6 to omcga-3 fatty acid ratio in the No Egg and Regular Egg
treatments were slightly higher than 10: 1, which is a simi lar ratio reported by Raper et aps The omega-6 to omega-3 fatty acid ratio in the
Omega Egg treatment was 7: I. This is an important consideration because both long-chain omega-6 and omega-3 fatty acids are used for
synthesis of specific eicosanoids as well as serving a functional role in
cellular membrane phospholipids.
Serum lipid concentrations were relatively unchanged by the addition of Regular Eggs or Omega Eggs to the diet Cfable 2). In a simi lar
study, Ferrier et al. 12 also found no significant differences in plasma total or HDL cholesterol concentration in subjects consuming either four
regular eggs or four omega-3 fatty acid-enriched eggs per day. In contrast, Oh et al. ll reported that plasma total cholesterol concentration was
significantly increased by consumption of regular eggs but unchanged
in subjects fed four omega-3 fatty acid-enriched eggs per day. Because
of the wide variation in serum lipid response seen in the human population, it is possible that our sample size was too small to detect a cholesterol-lowering effect of omega-3 fatty acids at the levels cunsumed in
our study. There were, however, three subjects whose serum total cholesterol concentration significantly increased dW'ing the Regular Egg
treatment (Table 4). The proportion of "cholesterol responders" to dietary cbolesterol in the present study (19%) is consistent with the proportion found in the general popUlation, which is estimated to be
15-20%26 There is now substantial evidence that while dietary cholesterol has little effect on serum cholesterol concentration in Lhe general
population,27,28 there exists a high degree of variability in the response
of individuals to dietary cho\csterol. 26 This conclusion is suppurted by
the present data, although one should be cautious ahout overemphasizing the results of only three subjects.
Dietary omega-3 fatty acids have been reported to lower serum
triaeylglycerol concentrations. 29 -32 Although Omega Egg consumption
significantly increased omega-3 fatty acid intake, no significant differences in serum triacylglycefol concentration was observed among treat-
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ments. In the three responders, Omega Egg consumption appeared to
prevent the tendency for serum triacylglycerol concentration to increase
when Regular Eggs were consumed. In a previous study, a fish oil diel
containing 24 g/day of omega-3 fatty acids significantly lowered plasma
triacylglycerol concentration Lower doses of fish oil (2-8 g/day of
omega-3 fatty acids) were also effective at reducing plasma triacylglycerol eoncentration 34 ,3S In the present study, the mean omega-3
fany acid intake was 1 18 g/day during Omega Egg treatment. While
this level of intake was significantly higher than No Egg or Regular Egg
treatment, it was apparently too low to elicit a significant change in serum lriacylglycerol concentration.
Another objective of this study was (0 measure the compositional
changes in serum LDL particles as influenced by dietary omega-3 fatty
acids. No significant compositional changes were detected in the major
lipid components of LDL Our results are consistent with S0rensen et
a]36 who reported no effect of omega-3 fatty acid consumption (- I
g/day) on LDL chemical composition or size. Grealer dietary intake of
omega-3 fatty acids may be required to elicit changes in LDL composition or to enrich LDL lipids with omega-3 fatty acids.

CONCLUSIONS
The inclusion of Omega Eggs (12/weck) to the NCEP Step I uiet significantly increased the omega-3 fatty acid content of the diet approximately 400-500 mg/day. Omega Egg consumption also appeared to
prevent an increase in serum total cholesterol concentration in three individuals who appeared to he "responders" to dietary cholesterol. These
data suggest a therapeutic use of Omega Eggs in managing serum cholesterol in l11dividuals who are sensitive to dietaty cholesterol. In this
way, tbe nutritional benefits of eggs could be realized without the detrimental effects of increased cholesterol intake.
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